Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

Share Price is delayed by 15 minutes
Get Live Data
94.50    2.30 (2.49%)
Bid:
94.10
Ask:
94.40
Spread: 0.30 (0.319%)
Market Cap: £348.08m
CCR Live PriceLast checked at - London Stock Exchange

Intraday C&C Group Share Chart

Board Changes

14 Jan 2025 07:00

RNS Number : 1558T
C&C Group Plc
14 January 2025
 

This announcement contains inside information.

C&C Group plc

("C&C" or "the Group")

Board Changes

C&C Group plc, the vertically integrated premium branded drinks group and leading drinks distributor to the UK and Ireland hospitality sectors, announces the following Board changes:

John Gibney has informed the Board of his intention to step down as a Non-Executive Director of the Group, with effect from 13 January 2025. John has worked closely with Andrew Andrea, Chief Financial and Transformation Officer, to deliver substantial improvement in the Group's risk and internal control processes. As such, he now feels this is an appropriate time for him to step down and the new leadership team to continue this work.

John will be succeeded by Feargal O'Rourke, Non-Executive Director, as Chair of the Audit Committee. During a 37 year career with PwC, latterly serving as Managing Partner in Ireland until his retirement from the professional services firm in October 2023, Feargal advised Irish and international companies on a broad range of financial issues including investment, financing and business structuring. In January 2024, he was appointed by Ireland's Minister for Enterprise, Trade and Employment as Chair of IDA Ireland and is also Chair of the Institute of International and European Affairs, the Irish based international think tank.

 

In addition, Mark Chilton, Company Secretary and Group General Counsel, has notified the Board that he will retire on 31 August 2025. Gillian Kyle, currently Deputy Company Secretary, will take on the role of Company Secretary with effect from the close of the 2025 AGM. A highly experienced company secretariat professional, Gillian joined C&C in 2023 from The Weir Group PLC where she was Deputy Company Secretary (2015-2023), having previously held a similar role at Aggreko plc from 2008-2015.

As previously announced, Ralph Findlay will return to the position of Non-Executive Chair as of 1 March 2025 following a short period of transition after Roger White joins the business as Chief Executive Officer on 20 January 2025. Ralph will also resume the role of Chair of the Nomination Committee at that time.

Ralph Findlay, Chair and CEO of C&C Group plc, commented:

"On behalf of the Company and the Board, I would like to thank John for his significant contribution to C&C during his tenure with the business. We wish John every success for the future and are delighted to welcome Feargal to the role of Audit Committee Chair.

"I would also like to thank Mark for his dedication and commitment to the business over the last six years with the Group. We wish him well in his retirement later this year and look forward to Gillian supporting the Board as Company Secretary."

This announcement has been made in accordance with the requirements of Listing Rule 6.4.6 and there is no further information to be disclosed under the requirements of Listing Rule 6.4.8.

14 January 2025

 

ENQUIRIES

C&C Group plc

Email: investor.relations@candcgroup.ie

Instinctif Partners T: +44 (0)20 7457 2020

Justine Warren/ Tim Pearson/ Amelia Thorn

Email: candccapmkts@instinctif.com

 

Irish Media

FTI Consulting

Jonathan Neilan / Paddy Berkery / Niamh O'Brien

Tel: +353 86 231 4135 / +353 86 602 5988 / +353 87 707 8379

Email: C&CGroup@fticonsulting.com

 

About C&C Group plc

C&C Group plc is a leading, vertically integrated premium drinks company which manufactures, markets and distributes branded beer, cider, wine, spirits, and soft drinks across the UK and Ireland.

· C&C Group's portfolio of owned/exclusive brands include Bulmers, the leading Irish cider brand and Tennent's, the leading Scottish beer brand; as well as a range of fast-growing, premium and craft ciders and beers, such as Heverlee, Menabrea, Five Lamps and Orchard Pig. C&C exports its Magners and Tennent's brands to over 40 countries worldwide.

· C&C Group has owned brand and contract manufacturing/packing operations in Co.Tipperary, Ireland and Glasgow, Scotland.

· C&C is the No.1 drinks distributor to the UK and Ireland hospitality sectors. Operating through the Matthew Clark, Bibendum, Tennent's and Bulmers Ireland brands, the Group has a market leading range, scale and reach including an intimate understanding of the markets it serves. Together this provides a key route-to-market for major international beverage companies.

C&C Group plc is an Irish incorporated FTSE 250 company headquartered in Dublin and is listed on the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABRGDBDUBDGUX
Date   Source Headline
15th Feb 20247:00 amRNSDirectorate Changes
2nd Feb 202410:00 amRNSTotal Voting Rights and Capital
15th Jan 20242:20 pmRNSDirector/PDMR Shareholding
4th Jan 202412:45 pmRNSTotal Voting Rights
18th Dec 20233:30 pmRNSDirector/PDMR Shareholding
12th Dec 20231:05 pmRNSHolding(s) in Company
6th Dec 20233:30 pmRNSDirectorate Change
5th Dec 20232:10 pmRNSBlock listing Interim Review
4th Dec 202311:15 amRNSTotal Voting Rights and Capital
16th Nov 20236:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20232:56 pmRNSHolding(s) in Company
2nd Nov 202312:44 pmRNSDirector/PDMR Shareholding
31st Oct 20233:00 pmRNSTotal Voting Rights
30th Oct 20233:45 pmRNSDirector/PDMR Shareholding
26th Oct 20237:00 amBUSHalf-year Report
16th Oct 20235:16 pmRNSDirector/PDMR Shareholding
6th Oct 202312:30 pmRNSHolding(s) in Company
27th Sep 20233:56 pmRNSHolding(s) in Company
19th Sep 20237:00 amBUSStatement re FY2024 H1 pre-close Trading Statement
15th Sep 20232:10 pmRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSDirectorate Changes
18th Aug 20239:35 amRNSDirector Declaration
16th Aug 20234:15 pmRNSDirector/PDMR Shareholding
20th Jul 20239:00 amRNSDirector Declaration
17th Jul 20233:15 pmRNSDirector/PDMR Shareholding
13th Jul 20231:00 pmRNSResult of AGM
13th Jul 20237:00 amBUSAGM Statement
6th Jul 20234:00 pmRNSHolding(s) in Company
3rd Jul 20235:45 pmRNSHolding(s) in Company
26th Jun 202312:06 pmRNSHolding(s) in Company
16th Jun 20232:00 pmRNSDirector/PDMR Shareholding
14th Jun 20236:05 pmRNSDirector/PDMR Shareholding
14th Jun 20238:30 amRNSAnnual Report & Notice of AGM
13th Jun 20234:30 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSBlock listing Interim Review
30th May 20237:00 amRNSHolding(s) in Company
26th May 202312:15 pmRNSDirector/PDMR Shareholding
24th May 20231:45 pmRNSDirector/PDMR Shareholding
24th May 202312:00 pmRNSDirector/PDMR Shareholding
24th May 20237:00 amBUSFinal Results
19th May 20237:00 amBUSStatement re Trading Update & Directorate Changes
16th May 20232:00 pmRNSDirector/PDMR Shareholding
4th May 20231:30 pmRNSHolding(s) in Company
17th Apr 20233:45 pmRNSDirector/PDMR Shareholding
23rd Mar 20237:00 amBUSPre-close Trading Statement
16th Mar 20233:15 pmRNSDirector/PDMR Shareholding
15th Mar 20232:00 pmRNSHolding(s) in Company
23rd Feb 202311:00 amRNSHolding(s) in Company
15th Feb 20234:15 pmRNSDirector/PDMR Shareholding
10th Feb 20232:19 pmBUSStatement re Directorate Changes and Board Committee Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.